Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
There are several reasons people might want to switch: Weight loss plateaus after a few months on semaglutide Gastrointestinal side effects like nausea or constipation that are not manageable Desire for better glucose control Personal goals (e.g., prefer faster weight loss progress ) In my practice, the most common reasons I recommend patients to switch medication is 1) they are having uncomfortable or unmanageable side effects from semaglutide including heart burn, nausea, constipation or 2) their weight loss starts to plateau before they reach their weight loss goals
:format(webp))
Retatrutide in research settings typically arrives as lyophilized powder requiring reconstitution with bacteriostatic water
Injections are extra support for people needing more help to lose weight
However, GLP-1 agonists like semaglutide have more established long-term safety data
Rosenstock J, Allison D, Birkenfeld AL et al (2019) Effect of additional oral semaglutide vs sitagliptin on glycated hemoglobin in adults with type 2 diabetes uncontrolled with metformin alone or with sulfonylurea: the PIONEER 3 randomized clinical trial
Pfizer Headquarters: New York, New York, USA Number of employees: 81,000 Year founded: 1849 Revenue (2025): $63.6 billion Forbes overall rank: 305 Pfizer generated around $62 billion in revenue in 2025, reflecting a transition period as COVID-19 product sales decline and the company pivots toward new growth areas
US$ 29.86
US$ 28.65
US$ 28.82
US$ 21.39
US$ 21.39
